HopeStage
Back to all studies
Active Not RecruitingNCT07111390

Home-based intermittent light therapy for major depression

About this titleRead the official source — NCT07111390
Device studyAges 24–65United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 24 years to 65 years. Other eligibility criteria apply.

Listed locations
New YorkSee all locations and recruitment
Participation format
Remote participation

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 18, 2025
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
40
Sponsor
NYU Langone Health
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 24 Years to 65 Years
Official registry ID
NCT07111390
Official title
Show the full official title

A Feasibility Pilot Study of Home-Based Intermittent 60Hz Light Therapy for the Treatment of Depression

Recruitment & locations

Not recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NYU Langone Health.

Who can participate?

This study is for people with depression. Listed age limits: 24 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies